X-linked agammaglobulinemia is an inherited immunodeficiency recognized since 1952. In spite of seven decades of experience, there is still a limited understanding of regional differences in presentation and complications. This study was designed by the Primary Immunodeficiencies Committee of the World Allergy Organization to better understand regional needs, challenges and unique patient features.
El-Sayed, Z.a., Abramova, I., Aldave, J.c., Al-Herz, W., Bezrodnik, L., Boukari, R., et al. (2019). X-linked agammaglobulinemia (XLA):Phenotype, diagnosis, and therapeutic challenges around the world. THE WORLD ALLERGY ORGANIZATION JOURNAL, 12(3), 100018 [10.1016/j.waojou.2019.100018].
X-linked agammaglobulinemia (XLA):Phenotype, diagnosis, and therapeutic challenges around the world
Cancrini C.;Moschese V.;
2019-01-01
Abstract
X-linked agammaglobulinemia is an inherited immunodeficiency recognized since 1952. In spite of seven decades of experience, there is still a limited understanding of regional differences in presentation and complications. This study was designed by the Primary Immunodeficiencies Committee of the World Allergy Organization to better understand regional needs, challenges and unique patient features.| File | Dimensione | Formato | |
|---|---|---|---|
|
XLA.pdf
solo utenti autorizzati
Licenza:
Copyright dell'editore
Dimensione
582.82 kB
Formato
Adobe PDF
|
582.82 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
